XML 108 R76.htm IDEA: XBRL DOCUMENT v3.6.0.2
Business Combinations (NPS Pro Forma Information) (Details) - NPS Pharma - USD ($)
$ / shares in Units, $ in Millions
9 Months Ended 12 Months Ended
Sep. 30, 2015
Dec. 31, 2015
Business Acquisition [Line Items]    
Revenues   $ 6,446.6
Net income from continuing operations   $ 1,293.6
Net income from continuing operations per share - basic   $ 2.19
Net income from continuing operations per share - diluted   $ 2.18
Increase/(decrease) to net income to reflect acquisition related costs $ 105.3  
Increase/(decrease) to net income to reflect the fair value adjustment to acquisition date inventory. $ 18.8  
An adjustment to increase amortization of intangible assets   $ 22.2